Trials / Completed
CompletedNCT02658149
Psoas Compartment Block Versus Periarticular Local Anesthetic for Total Hip Arthroplasty
Psoas Compartment Block Versus Periarticular Local Anesthetic Infiltration for Pain Management for Total Hip Arthroplasty: A Prospective, Randomized Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Corewell Health East · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to examine whether there is a difference in the level of resting pain following total hip arthroplasty with an anterior approach with use of a psoas compartment block versus a local periarticular anesthetic infiltration
Detailed description
A single-center, prospective, randomized clinical trial with a total of 100 patients. One orthopaedic adult reconstruction surgeon at Beaumont Hospital Royal Oak (JJV) will perform all surgeries. After the patient has consented they will be randomized to one of the following two groups: 1. Psoas compartment block (n=50) 2. Periarticular local anesthetic infiltration (n=50), The patient will be blinded to the study group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine with NaCl | 50 mL (40 mL of 0.2% Ropivicaine and 10 mL of 0.9% NaCl) are administered into the psoas compartment |
| DRUG | Epinephrine | 0.15 mg Epinephrine are injected as part of the drug "cocktail" |
| DRUG | Morphine | 4 mg Morphine are injected as part of the drug "cocktail" |
| DRUG | Ketorolac Tromethamine | 30 mg morphine are injected as part of the drug "cocktail" |
| DRUG | Ropivacaine | 30 mL 0.5% Ropivicaine are injected as part of the drug "cocktail" |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-05-11
- Completion
- 2017-06-02
- First posted
- 2016-01-18
- Last updated
- 2018-05-09
- Results posted
- 2018-04-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02658149. Inclusion in this directory is not an endorsement.